CD40LG and COVID-19: It has been suggested that high levels of IgM and IgG antibodies against the S1 and N proteins, in the first 15 days post-symptom onset (PSO), is considered a risk factor for a more severe clinical outcomes, since these antibodies were detected at higher levels in COVID-19 patients admitted to the intensive care unit (ICU) and in those who died (12–14).